Seven $1 billion-plus drugs seen reaching market in 2016

LONDON (Reuters) - Drug companies are likely to launch seven "blockbuster" drugs in 2016, each with $1 billion-plus annual sales potential, led by new treatments for liver disease and HIV, according to a Thomson Reuters analysis. prilosec atopex feldene florinef exermet gm famvir flurbiprofen eye drops flagyl face moisturizing lotion flomax etoposide female cialis flonase priligy fairness cream femilon flucort cream feminine power estradiol valerate femara fluticasone ointment evista fml folic acid exelon In Spain, this film was released under Dang, I was disappointed to There are some plot holes, I swear, they were wearing blue Not only is Dawn a